[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 1017
91. Yoshikawa R, Yanagi H, Shen CS, Fujiwara Y, Noda M, Yagyu T, Gega M, Oshima T, Yamamura T, Okamura H, Nakano Y, Morinaga T, Hashimoto-Tamaoki T: ECA39 is a novel distant metastasis-related biomarker in colorectal cancer. World J Gastroenterol; 2006 Sep 28;12(36):5884-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] ECA39 is a novel distant metastasis-related biomarker in colorectal cancer.
  • AIM: To investigate the possible role of polysaccharide-K (PSK) -related markers in predicting distant metastasis and in the clinical outcome of colorectal cancer (CRC).
  • METHODS: Firstly, we used protein microarrays to analyze the in vitro expression profiles of potential PSK-related markers in the human colorectal adenocarcinoma cell line SW480, which carries a mutant p53 gene.
  • [MeSH-major] Adenocarcinoma / metabolism. Biomarkers, Tumor / metabolism. Colorectal Neoplasms / metabolism. Neoplasm Metastasis / genetics. Transaminases / metabolism

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 2000 Sep 15;89(6):1228-35 [11002217.001]
  • [Cites] J Clin Oncol. 2000 Jul;18(13):2515-21 [10893281.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9433-8 [12093899.001]
  • [Cites] J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99 [12953083.001]
  • [Cites] Br J Cancer. 2003 Nov 3;89(9):1757-65 [14583781.001]
  • [Cites] Br J Cancer. 2004 Mar 8;90(5):1003-10 [14997197.001]
  • [Cites] Expert Rev Anticancer Ther. 2004 Apr;4(2):289-302 [15056059.001]
  • [Cites] Int J Immunopharmacol. 1983;5(1):35-42 [6220984.001]
  • [Cites] Cancer Immunol Immunother. 1986;22(3):181-5 [3731203.001]
  • [Cites] Cell. 1990 Jun 1;61(5):759-67 [2188735.001]
  • [Cites] Nucleic Acids Res. 1990 Nov 25;18(22):6709 [2251142.001]
  • [Cites] Cancer Immunol Immunother. 1991;32(6):335-41 [1901030.001]
  • [Cites] Lymphokine Res. 1990 Winter;9(4):475-83 [2090874.001]
  • [Cites] Cell Growth Differ. 1993 Feb;4(2):57-65 [8494784.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7804-8 [8356088.001]
  • [Cites] Genes Dev. 1992 Dec;6(12B):2513-23 [1340466.001]
  • [Cites] Gastroenterology. 1994 Jan;106(1):42-8 [8276207.001]
  • [Cites] Cell Growth Differ. 1993 Nov;4(11):879-83 [8297793.001]
  • [Cites] Lancet. 1994 May 7;343(8906):1122-6 [7910230.001]
  • [Cites] Lancet. 1994 Jul 23;344(8917):233-4 [7913159.001]
  • [Cites] Am J Clin Oncol. 1995 Jun;18(3):216-22 [7747709.001]
  • [Cites] Anticancer Res. 1995 Mar-Apr;15(2):255-8 [7762991.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7143-8 [8692959.001]
  • [Cites] Nature. 1996 Aug 8;382(6591):511-7 [8700224.001]
  • [Cites] J Biol Chem. 1996 Aug 23;271(34):20242-5 [8702755.001]
  • [Cites] Cancer Detect Prev. 1997;21(1):71-7 [9043766.001]
  • [Cites] Oncol Rep. 2004 Dec;12(6):1287-93 [15547752.001]
  • [Cites] J Clin Oncol. 2005 Apr 20;23(12):2645-54 [15728227.001]
  • [Cites] CA Cancer J Clin. 2000 Jan-Feb;50(1):7-33 [10735013.001]
  • [Cites] Cancer Res. 2001 Feb 1;61(3):1029-37 [11221829.001]
  • (PMID = 17007058.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 0 / Biomarkers, Tumor; 0 / Proteoglycans; 0 / Tumor Suppressor Protein p53; 66455-27-4 / krestin; EC 2.6.1. / BCAT1 protein, human; EC 2.6.1.- / Transaminases
  • [Other-IDs] NLM/ PMC4100673
  •  go-up   go-down


92. Saltzstein SL, Behling CA: Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: a study of 213,383 cases from the California Cancer Registry. J Clin Gastroenterol; 2007 Feb;41(2):173-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: a study of 213,383 cases from the California Cancer Registry.
  • GOALS: Using a data set of more than 200,000 cases, we can measure the effects of age, time, sex, and race/ethnicity on the shift of the site of origin of colorectal adenocarcinoma from the left to the right side.
  • BACKGROUND: As people become older, there is a shift of the site of origin of adenocarcinoma of the colorectum from the left to the right side.
  • Although some studies do show some relationship of this shift, in addition to age, to race/ethnicity and to sex, there are no large, total population-based data studying the effects of these factors and time trends in this shift.
  • STUDY: 213,383 cases of adenocarcinoma of the colorectum for the years 1988 to 2003 from the California Cancer Registry have been studied.
  • RESULTS: The left-to-right shift increases significantly with increasing age and year of diagnosis, and is greater in women than in men and is greater in whites than in other racial/ethnic groups.
  • The time-related shift is a reflection of a lesser decrease in the incidence of colorectal adenocarcinoma on the right side than on the left.
  • [MeSH-major] Adenocarcinoma / pathology. Aging. Colorectal Neoplasms / pathology. Registries

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Seniors' Health.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17245216.001).
  • [ISSN] 0192-0790
  • [Journal-full-title] Journal of clinical gastroenterology
  • [ISO-abbreviation] J. Clin. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


93. Kong KV, Leong WK, Ng SP, Nguyen TH, Lim LH: Osmium carbonyl clusters: a new class of apoptosis inducing agents. ChemMedChem; 2008 Aug;3(8):1269-75
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osmium carbonyl clusters, especially the cluster [Os(3)(CO)(10)(NCCH(3))(2)], were found to be active against four cancer cell lines, namely, ER+ breast carcinoma (MCF-7), ER- breast carcinoma (MDA-MB-231), metastatic colorectal adenocarcinoma (SW620), and hepatocarcinoma (Hep G2).

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. OSMIUM COMPOUNDS .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18433076.001).
  • [ISSN] 1860-7187
  • [Journal-full-title] ChemMedChem
  • [ISO-abbreviation] ChemMedChem
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Osmium Compounds
  •  go-up   go-down


9
Advertisement
4. Chen Y, Zhang CL, Shen YQ, Wang LC: Bioinformatics Analysis and Validation of the Expressed Sequences Tag in Human Colorectal Adenocarcinoma. Gastroenterology Res; 2009 Apr;2(2):110-114
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bioinformatics Analysis and Validation of the Expressed Sequences Tag in Human Colorectal Adenocarcinoma.
  • BACKGROUND: This study was to investigate some new pathological genes in colorectal adenocarcinoma of human.
  • METHODS: Human colorectal adenocarcinoma tissues and normal colorectal tissues were taken and suppression subtractive hybridization (SSH) and cDNA microarray techniques were employed.
  • RESULTS: Among these 10 EST, it has been found that ES274070, ES274071, ES274076 and ES274081 may play role in the onset of colorectal adenocarcinoma in human.
  • CONCLUSIONS: The ES274070, ES274071, ES274076 and ES274081 are related to the onset of human colorectal adenocarcinoma.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27956963.001).
  • [ISSN] 1918-2805
  • [Journal-full-title] Gastroenterology research
  • [ISO-abbreviation] Gastroenterology Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Keywords] NOTNLM ; Bioinformatic analyses / Colorectal adenocarcinoma / Expressed sequence tag
  •  go-up   go-down


95. Fan LF, Dong WG, Jiang CQ, Xia D, Liao F, Yu QF: Expression of putative stem cell genes Musashi-1 and beta1-integrin in human colorectal adenomas and adenocarcinomas. Int J Colorectal Dis; 2010 Jan;25(1):17-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of putative stem cell genes Musashi-1 and beta1-integrin in human colorectal adenomas and adenocarcinomas.
  • This study was to detect expressions of the two genes in colorectal adenomas and carcinomas and to analyze the correlation between Musashi-1 and beta1-integrin.
  • METHODS: Musashi-1 and beta1-integrin immunoreactivity was studied immunohistochemically in tissue microarray-based samples containing 69 colorectal adenocarcinomas, eight normal mucosa, and eight adenomas, and their messenger RNA (mRNA) expression level was detected by RT-PCR in resected specimens including the three types of tissue.
  • RESULTS: A percentage of 66.7% (46/69) and 59.2% (41/69) of colorectal adenocarcinomas were immunoreactive with Musashi-1 and beta1-integrin, respectively.
  • beta1-integrin expression was higher in group of adenocarcinomas than that of adenomas (P = 0.0276).
  • Significant differences of Musashi-1 and beta1-integrin mRNA expression levels were found between the normal colorectal mucosa, adenoma, and adenocarcinoma tissues (P = 0.01; P = 0.03, respectively).
  • CONCLUSIONS: Musashi-1 and beta1-integrin may be involved in human colorectal tumor carcinogenesis and progression.
  • [MeSH-major] Adenocarcinoma / genetics. Adenoma / genetics. Antigens, CD29 / genetics. Colorectal Neoplasms / genetics. Gene Expression Regulation, Neoplastic. Nerve Tissue Proteins / genetics. RNA-Binding Proteins / genetics. Stem Cells / metabolism


96. Wang LM, Kevans D, Mulcahy H, O'Sullivan J, Fennelly D, Hyland J, O'Donoghue D, Sheahan K: Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. Am J Surg Pathol; 2009 Jan;33(1):134-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer.
  • BACKGROUND: Tumor budding along the advancing front of colorectal adenocarcinoma is an early event in the metastatic process.
  • A reproducible, prognostic budding scoring system based on outcomes in early stage colorectal cancer has not been established.
  • DESIGN: One hundred twenty-eight T3N0M0 colorectal carcinoma patients with known outcome were identified.
  • [MeSH-major] Adenocarcinoma / pathology. Colorectal Neoplasms / pathology. Cytological Techniques / methods

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18971777.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. Vidic S, Markelc B, Sersa G, Coer A, Kamensek U, Tevz G, Kranjc S, Cemazar M: MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivo. Cancer Gene Ther; 2010 Jun;17(6):409-19
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivo.
  • Mutations of K-ras have been found in 30-60% of colorectal carcinomas and are believed to be associated with tumor initiation, tumor progression and metastasis formation.
  • Therefore, silencing of mutant K-ras expression has become an attractive therapeutic strategy for colorectal cancer treatment.
  • The aim of our study was to investigate the effect of microRNA (miRNA) molecules directed against K-ras (miRNA-K-ras) on K-ras expression level and the growth of colorectal carcinoma cell line LoVo in vitro and in vivo.
  • The obtained results demonstrate that electrogene therapy with miRNA-K-ras molecules can be potential therapeutic strategy for treatment of colorectal cancers harboring K-ras mutations.
  • [MeSH-major] Adenocarcinoma / therapy. Colorectal Neoplasms / therapy. MicroRNAs / genetics. Mutation. ras Proteins / genetics

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20094071.001).
  • [ISSN] 1476-5500
  • [Journal-full-title] Cancer gene therapy
  • [ISO-abbreviation] Cancer Gene Ther.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / MicroRNAs; 0 / RNA, Small Interfering; EC 3.6.5.2 / ras Proteins
  •  go-up   go-down


98. Tokai H, Kawashita Y, Eguchi S, Kamohara Y, Takatsuki M, Okudaira S, Tajima Y, Hayashi T, Kanematsu T: A case of mucin producing liver metastases with intrabiliary extension. World J Gastroenterol; 2006 Aug 14;12(30):4918-21
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 75-year-old man was admitted to our hospital with a diagnosis of liver metastases from colon cancer.
  • Histopathological examination of the resected specimens from both operations revealed a well-differentiated adenocarcinoma with mucinous carcinoma.
  • With a tentative diagnosis of a recurrence of metastatic cancer, partial hepatectomy of S8 was performed.
  • Histological examination of the resected specimens also revealed mucinous adenocarcinoma, which had invaded into the biliary ducts, replacing and extending along its epithelium.
  • Therefore, the tumor was diagnosed as a metastatic adenocarcinoma from colonic cancer.
  • Liver metastases of colorectal adenocarcinoma sometimes invade the Glisson's triad and grow along the biliary ducts.
  • [MeSH-major] Adenocarcinoma. Bile Duct Neoplasms / metabolism. Bile Duct Neoplasms / secondary. Colonic Neoplasms / pathology. Liver Neoplasms / metabolism. Liver Neoplasms / secondary. Mucins / metabolism
  • [MeSH-minor] Aged. Diagnosis, Differential. Humans. Male. Neoplasm Metastasis

  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Gastroenterol. 2004 Jan;39(1):72-5 [14767739.001]
  • [Cites] World J Gastroenterol. 2003 Feb;9(2):193-200 [12532430.001]
  • [Cites] AJR Am J Roentgenol. 1981 Feb;136(2):345-8 [6258409.001]
  • [Cites] Radiology. 1981 Dec;141(3):733-6 [6272354.001]
  • [Cites] Surgery. 1986 Aug;100(2):278-84 [3526605.001]
  • [Cites] World J Surg. 1987 Aug;11(4):541-7 [3630198.001]
  • [Cites] Ann Surg. 1995 Jan;221(1):74-8 [7826164.001]
  • [Cites] Dis Colon Rectum. 1996 Aug;39(8):847-51 [8756838.001]
  • [Cites] Jpn J Clin Oncol. 1997 Feb;27(1):18-21 [9070335.001]
  • [Cites] Am J Surg. 1997 Jun;173(6):467-71 [9207156.001]
  • [Cites] Cancer. 1999 Jan 1;85(1):171-7 [9921990.001]
  • [Cites] Ann Surg. 2005 May;241(5):715-22, discussion 722-4 [15849507.001]
  • [Cites] Surgery. 1999 Nov;126(5):829-34 [10568181.001]
  • [Cites] Am J Surg Pathol. 2000 Jun;24(6):870-6 [10843291.001]
  • [Cites] Pathol Int. 2002 Aug;52(8):514-8 [12366810.001]
  • [Cites] AJR Am J Roentgenol. 1978 Nov;131(5):839-42 [101040.001]
  • (PMID = 16937483.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Mucins
  • [Other-IDs] NLM/ PMC4087635
  •  go-up   go-down


99. Aljarabah MM, Borley NR, Wheeler JM: Appendiceal adenocarcinoma presenting as left-sided large bowel obstruction, a case report and literature review. Int Semin Surg Oncol; 2007;4:20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Appendiceal adenocarcinoma presenting as left-sided large bowel obstruction, a case report and literature review.
  • Herein we present a case of appendiceal adenocarcinoma presenting as left-sided large bowel obstruction, we also review the literature of unusual presentations of appendiceal tumours.
  • CASE PRESENTATION: we report a case of left sided large bowel obstruction found to be secondary to an appendiceal adenocarcinoma.
  • The patient presented with abdominal pain, distension and constipation, CT scan showed large bowel obstruction thought to be due to a sigmoid tumour, on laparotomy the appendix was also noted to be abnormal.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Abdom Imaging. 1999 Mar-Apr;24(2):193-5 [10024411.001]
  • [Cites] Surg Today. 2000;30(1):78-81 [10648090.001]
  • [Cites] Cir Cir. 2004 Sep-Oct;72(5):375-8 [15550226.001]
  • [Cites] Colorectal Dis. 2006 May;8 Suppl 1:20-4 [16594960.001]
  • [Cites] J Gastroenterol Hepatol. 2006 Jun;21(6):1079-81 [16725004.001]
  • [Cites] Dis Colon Rectum. 1998 Jan;41(1):75-80 [9510314.001]
  • [Cites] Gynecol Oncol. 1982 Apr;13(2):265-8 [7076041.001]
  • [Cites] J Urol. 1980 Jan;123(1):123 [7351705.001]
  • [Cites] Dis Colon Rectum. 1977 Mar;20(2):130-4 [844397.001]
  • [Cites] Br J Urol. 1996 Aug;78(2):305-6 [8813936.001]
  • [Cites] Br J Surg. 2006 Jul;93(7):783-92 [16775823.001]
  • (PMID = 17662117.001).
  • [ISSN] 1477-7800
  • [Journal-full-title] International seminars in surgical oncology : ISSO
  • [ISO-abbreviation] Int Semin Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1948007
  •  go-up   go-down


100. Lee EK, Han GY, Park HW, Song YJ, Kim CW: Transgelin promotes migration and invasion of cancer stem cells. J Proteome Res; 2010 Oct 1;9(10):5108-17
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Similar results were also observed in tumorigenic cells derived from colorectal adenocarcinoma and prostate carcinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20707403.001).
  • [ISSN] 1535-3907
  • [Journal-full-title] Journal of proteome research
  • [ISO-abbreviation] J. Proteome Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / AC133 antigen; 0 / Antigens, CD; 0 / Glycoproteins; 0 / Microfilament Proteins; 0 / Muscle Proteins; 0 / Peptides; 0 / transgelin
  •  go-up   go-down






Advertisement